KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Royalty Pharma (RPRX) Acquisitions (2025)

Royalty Pharma (RPRX) has disclosed Acquisitions for 1 consecutive years, with $226000.0 as the latest value for Q3 2025.

  • Quarterly Acquisitions changed N/A to $226000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $226000.0 through Dec 2025, changed N/A year-over-year, with the annual reading at $74.4 million for FY2025, N/A changed from the prior year.
  • Acquisitions hit $226000.0 in Q3 2025 for Royalty Pharma.
  • In the past five years, Acquisitions ranged from a high of $226000.0 in Q3 2025 to a low of $226000.0 in Q3 2025.